A 76-year-old with HFrEF on ACEi, beta-blocker, MRA, and SGLT2 inhibitor remains symptomatic. He is not Black. Which additional therapy improves outco...

Question

A 76-year-old with HFrEF on ACEi, beta-blocker, MRA, and SGLT2 inhibitor remains symptomatic. He is not Black. Which additional therapy improves outcomes?

Accepted Answer

Add ivabradine if sinus rate ≥70 on maximized beta-blocker

Answer

Vericiguat for all NYHA II

Answer

Hydralazine/isosorbide dinitrate (only) for any patient

Answer

Digoxin to reduce mortality

Answer

High-dose furosemide for mortality reduction

us-abim MCQ (SBA): Heart Failure (Therapies)

A 76-year-old with HFrEF on ACEi, beta-blocker, MRA, and SGLT2 inhibitor remains symptomatic. He is not Black. Which additional therapy improves outcomes?